Carlo Adams
Physical Medicine & Rehabilitation · Grosse Pointe Woods, MINPI 1124225255
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 32.7% of the total. Reporting peaked in 2019 at $1,170 and has fallen 84.2% since, to $185 in 2025. Among physical medicine & rehabilitation clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Scilex Pharmaceuticals Inc.$471
- Collegium Pharmaceutical, Inc.$220
- Averitas Pharma Inc.$189
- Nevro Corp.$135
- Ferring Pharmaceuticals Inc.$108
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,442100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $1,127 |
| Scilex Pharmaceuticals Inc. | 22 | $471 |
| Collegium Pharmaceutical, Inc. | 12 | $220 |
| Averitas Pharma Inc. | 7 | $189 |
| Nevro Corp. | 7 | $135 |
| Ferring Pharmaceuticals Inc. | 7 | $108 |
| Electronic Waveform Lab, Inc. | 3 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $102 |
| MDD US Operations, LLC | 6 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $76 |
| Merz North America, Inc. | 4 | $73 |
| Abbott | 4 | $73 |
| Azurity Pharmaceuticals, Inc. | 4 | $70 |
| Vertiflex, Inc. | 2 | $70 |
| Medtronic | 3 | $65 |
| Sentynl Therapeutics, Inc. | 5 | $64 |
| Virtus Pharmaceuticals LLC | 4 | $59 |
| Pfizer | 4 | $49 |
| Amgen | 3 | $49 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Assertio Therapeutics, Inc. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| GRT US Holding, Inc. | 2 | $27 |
| Biodelivery Sciences International, Inc. | 1 | $21 |
| SPR Therapeutics, Inc | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Pernix Therapeutics Holdings, Inc. | 1 | $13 |
| Kaleo, Inc. | 1 | $11 |
| Amarin Pharma, Inc. | 1 | $11 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$258
How this compares
$3,442 in reported general payments places this provider in the 90th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 19 | $14,236 |
| Buprenorphine | 61 | $12,865 |
| Hysingla ErHydrocodone Bitartrate | 17 | $11,438 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 331 | $7,748 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 339 | $6,385 |
| Diclofenac Sodium | 120 | $3,517 |
| Lidocaine | 35 | $2,437 |
| Naloxone Hcl | 31 | $2,013 |
| Oxycodone Hcl | 74 | $1,697 |
| Gabapentin | 236 | $1,384 |
| Pregabalin | 90 | $1,102 |
| Duloxetine Hcl | 68 | $870 |
| Tramadol Hcl ErTramadol Hcl | 18 | $860 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 34 | $639 |
| Tramadol Hcl | 54 | $364 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $220 | $14,23619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 469 physical medicine & rehabilitation providers in Michigan.
Other physical medicine & rehabilitation in Grosse Pointe Woods
- Edward DabrowskiRoseville$167K
- Erika ErlandsonAnn Arbor$54K
- Gianna Maria RodriguezAnn Arbor$41K
- Mathew SaffarianEast Lansing$24K
- Jason PeterTroy$20K
- David WiersemaSaginaw$17K
- Satyum ParikhWarren$11K
- Reginald KapteynMuskegon$11K
- Emily GladstoneGrand Rapids$10K
- In YoonDearborn$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.